Correction: Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs

摘要

Correction to : British Journal of Cancer (2017) 117 , 1495–1506; 10.1038/bjc.2017.317; published online 14 September 2017 The original version of this article contained an error in Fig.? 6A . The volumes of the tumour xenografts were incorrectly calculated. The correct figure and figure legend are below, where the volume has been calculated using V?=?length?×?width ~(2) ?×?π/6. The interpretation of the data and conclusions are not affected. Fig. 6 CPT sensitized HCC xenografts to EPI treatment. Nude mice were injected with SMMC-7721 cells. CPT, Camptothecin; EPI, epirubicin. Mice were treated with CPT, EPI or in combination (COM) twice a week for a total of three times. At the end of the experiments, tumours were excised and weighed at the end of the experiment. a Tumour growth curves for SMMC-7721 xenografts. b Representative images of excised tumours. c Excised xenograft tumours weights at the end of the experiment. n = 8–10; * p & 0.05 vs. Veh control. ~(#) p ?&?0.05 vs EPI